In AD specifically, Noel et al. [164] discovered altered GG patterns, including changes in GM1, GM2, GM3, GD1a/b, and GT1b and shifts in sulfatides and ceramides that correlate with amyloid and tau pathology or cognitive decline. The gene discussed is MAPT; the disease is Alzheimer disease.